(Q38695599)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26763420%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Epidermolysis Bullosa Acquisita: From Pathophysiology to Novel Therapeutic Options (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26763420%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

epidermolysis bullosa acquisita

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26763420%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Enno Schmidt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26763420%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Ralf J. Ludwig

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26763420%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Michael Kasperkiewicz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26763420%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Christian D Sadik

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26763420%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Katja Bieber

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26763420%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Rudolf A Manz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26763420%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Detlef Zillikens

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26763420%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

English

0 references

publication date

1 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26763420%20AND%20SRC:MED&resulttype=core&format=json

Journal of Investigative Dermatology

4 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26763420%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26763420%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26763420%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

24-33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26763420%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/jid.2015.356

4 March 2020

exact match

0 references

cites work

General aspects and mechanisms of peripheral neuropathy associated with bortezomib in patients with newly diagnosed multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

CXCR1/2 inhibition enhances pancreatic islet survival after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Inhibition of N-terminal ATPase on HSP90 attenuates colitis through enhanced Treg function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Blister-inducing antibodies target multiple epitopes on collagen VII in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Inhibition of HSP90 molecular chaperones: moving into the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Methylprednisolone blocks autoantibody-induced tissue damage in experimental models of bullous pemphigoid and epidermolysis bullosa acquisita through inhibition of neutrophil activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Effects of intravenous immunoglobulins on mice with experimental epidermolysis bullosa acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Autoantibody-induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Animal models to investigate pathomechanisms and evaluate novel treatments for autoimmune bullous dermatoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Flightless I: an actin-remodelling protein and an important negative regulator of wound repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

The Src family kinases Hck, Fgr, and Lyn are critical for the generation of the in vivo inflammatory environment without a direct role in leukocyte recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

PI3Kβ plays a critical role in neutrophil activation by immune complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Immunoadsorption in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

T and B cells target identical regions of the non-collagenous domain 1 of type VII collagen in epidermolysis bullosa acquisita.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

A pilot study on reparixin, a CXCR1/2 antagonist, to assess safety and efficacy in attenuating ischaemia-reperfusion injury and inflammation after on-pump coronary artery bypass graft surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Recombinant human IgA1 and IgA2 autoantibodies to type VII collagen induce subepidermal blistering ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Assessing the safety of biologic agents in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Caspase-1-independent IL-1 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

GM-CSF modulates autoantibody production and skin blistering in experimental epidermolysis bullosa acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Recombinant IL-6 treatment protects mice from organ specific autoimmune disease by IL-6 classical signalling-dependent IL-1ra induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Rituximab in treatment-resistant autoimmune blistering skin disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Metabolite analysis distinguishes between mice with epidermolysis bullosa acquisita and healthy mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Fcγ receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Broad requirement for terminal sialic acid residues and FcγRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

T cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Genome-wide mapping of gene-microbiota interactions in susceptibility to autoimmune skin blistering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Persistent autoantibody-production by intermediates between short-and long-lived plasma cells in inflamed lymph nodes of experimental epidermolysis bullosa acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Hsp90 blockade modulates bullous pemphigoid IgG-induced IL-8 production by keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Heat shock protein 90 is required for ex vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Heat shock protein 90: a pathophysiological factor and novel treatment target in autoimmune bullous skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Innate B cell helpers reveal novel types of antibody responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Blockade of autoantibody-initiated tissue damage by using recombinant fab antibody fragments against pathogenic autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

The cysteine-rich region of type VII collagen is a cystine knot with a new topology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

EndoS reduces the pathogenicity of anti-mCOL7 IgG through reduced binding of immune complexes to neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

The clinical development of MEK inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Identification of Quantitative Trait Loci in Experimental Epidermolysis Bullosa Acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Immunomodulatory effects of heat shock protein 90 inhibition on humoral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

Congenital epidermolysis bullosa acquisita: vertical transfer of maternal autoantibody from mother to infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non-responsive to conventional therapy: clinical outcome and post-treatment long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Autoimmunity to type VII collagen in SKH1 mice is independent of regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Clinical and immunopathological evaluation of epidermolysis bullosa acquisita

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Complement-fixing anti-type VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Enzymatic autoantibody glycan hydrolysis alleviates autoimmunity against type VII collagen

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Genetic identification and functional validation of FcγRIV as key molecule in autoantibody-induced tissue injury

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Overexpression of the Flii gene increases dermal-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisita

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Topically applied flightless I neutralizing antibodies improve healing of blistered skin in a murine model of epidermolysis bullosa acquisita

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Flightless I over-expression impairs skin barrier development, function and recovery following skin blistering

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Mucosal morbidity in patients with epidermolysis bullosa acquisita

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies)

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Pathogenicity of IgG subclass autoantibodies to type VII collagen: induction of dermal-epidermal separation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Evidence for pathogenicity of autoreactive T cells in autoimmune bullous diseases shown by animal disease models

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Autoantibodies to Multiple Epitopes on the Non-Collagenous-1 Domain of Type VII Collagen Induce Blisters

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Identification of the Skin Basement-Membrane Autoantigen in Epidermolysis Bullosa Acquisita

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021

Black patients of African descent and HLA-DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.356

7 January 2021